Year: 2025
Type: article
Study design: Observational Study
Abstract: Background: poisoning are lacking. Methods: poisoning patients. Untargeted serum metabolomics was performed to screen the differentially expressed metabolites. The quality control samples were used to evaluate the stability and reproducibility of ultra performance liquid chromatography quadrupole time-of-flight mass spectrometry (UPLC-QTOF-MS/MS) analytical system. The prognosis predictive metabolic biomarkers were identified by ROC curve analysis. Correlations between metabolic biomarkers and biochemical indicators were analyzed by Spearman's correlation analysis. Results: Significant differences were observed between the survival and death groups in clinical manifestations-such as gastrointestinal bleeding, dizziness, headache, delirious coma, infection, and shortness of breath-and in biochemical indicators, including alanine transaminase (ALT), aspartate transaminase (AST), prothrombin time and activated partial thromboplastin time (APTT). Metabolomic analysis identified 80 differentially expressed metabolites involved primarily in amino acid and unsaturated fatty acid metabolism. ROC analysis (AUC >0.9) screened nine potential metabolic biomarkers for predicting clinical outcomes: 9,10-Epoxyoctadecenoic acid, Phosphatidylinositol(16:0/18:2 (9Z,12Z)), N-Acetyl-L-aspartic acid, PI(20:3 (5Z,8Z,11Z)/18:0), Propionylcarnitine, Proline betaine, 4'-Methyl-(-)-epigallocatechin 3-(4-methyl-gallate), PG (18:1 (11Z)/22:6 (4Z,7Z,10Z,13Z,16Z,19Z)), and L-Proline. Notably, correlation analysis revealed that 9,10-Epoxyoctadecenoic acid was positively correlated with AST and activated partial thromboplastin time, whereas 4'-Methyl-(-)-epigallocatechin 3-(4-methyl-gallate), N-acetyl-L-aspartic acid, PI(16:0/18:2 (9Z,12Z)), PI(20:3 (5Z,8Z,11Z)/18:0), and Propionylcarnitine showed negative correlations with various liver and coagulation parameters. Conclusion: poisoning, with significant correlation to liver and coagulation injury. These biomarkers may facilitate early risk stratification and guide targeted therapeutic interventions. Limitations include small sample size and single-center retrospective design, which may restrict result generalizability.
Source: Frontiers in Pharmacology
Authors: Dan Zhu, Jie Zhong, Yarong Liu, Sicheng Zhang, Lianhong Zou
Institutions: Hunan Normal University, Hunan Provincial People's Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W4417181883